Literature DB >> 14990994

Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1.

Jared M Ordway1, Katy Williams, Tom Curran.   

Abstract

Fos and Ras function in both dependent and independent signal transduction pathways, and sustained activity of either oncogene is sufficient to induce cell transformation and tumorigenesis. Increased DNA (cytosine-5) methyltransferse (Dnmt1) activity is involved in the mechanism of transformation by both oncogenes, suggesting that inappropriate epigenetic transcription regulation may be a common route of oncogenesis, and that cell transformation may model aspects of the epigenetic deregulation that often occurs in tumors. Here, we have taken a microarray-based gene expression approach to identify differentially expressed genes in cells transformed by c-fos, v-fos, ras or Dnmt1. The cohort of genes differentially expressed in all four transformation systems includes an over-representation of repressed genes, many of which have been functionally implicated in the suppression of transformation or tumorigenesis. Furthermore, we identified four potential tumor suppressor genes subject to epigenetic transcriptional repression in transformed cells. The results emphasize the role of transcription repression in oncogenesis, and they provide insights into the potential common epigenetic mechanisms impacting cell transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990994     DOI: 10.1038/sj.onc.1207483

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis.

Authors:  J Huang; A Stewart; B Maity; J Hagen; R L Fagan; J Yang; D E Quelle; C Brenner; R A Fisher
Journal:  Oncogene       Date:  2013-09-02       Impact factor: 9.867

Review 2.  The new field of epigenomics: implications for cancer and other common disease research.

Authors:  H T Bjornsson; H Cui; D Gius; M D Fallin; A P Feinberg
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2004

3.  AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins.

Authors:  Heather J Spence; Lynn McGarry; Catherine S Chew; Neil O Carragher; Linda A Scott-Carragher; Zhengqiang Yuan; Daniel R Croft; Michael F Olson; Margaret Frame; Bradford W Ozanne
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.

Authors:  Sungeun Kim; Christopher T Denny; Ron Wisdom
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta.

Authors:  Bradley Yates; Craig Zetterberg; Vaishali Rajeev; Michael Reiss; Susan R Rittling
Journal:  Exp Cell Res       Date:  2007-08-01       Impact factor: 3.905

Review 6.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

7.  Microarray transfection analysis of conserved genomic sequences from three immediate early genes.

Authors:  Xiaomei Ren; Michael D Uhler
Journal:  Genomics       Date:  2008-11-08       Impact factor: 5.736

8.  Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.

Authors:  Tal Teitz; Madoka Inoue; Marcus B Valentine; Kejin Zhu; Jerold E Rehg; Wei Zhao; David Finkelstein; Yong-Dong Wang; Melissa D Johnson; Christopher Calabrese; Marcelo Rubinstein; Razqallah Hakem; William A Weiss; Jill M Lahti
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

9.  Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

Authors:  Eddy H J van Roon; Marjo van Puijenbroek; Anneke Middeldorp; Ronald van Eijk; Emile J de Meijer; Dianhdra Erasmus; Kim A D Wouters; Manon van Engeland; Jan Oosting; Frederik J Hes; Carli M J Tops; Tom van Wezel; Judith M Boer; Hans Morreau
Journal:  BMC Cancer       Date:  2010-05-05       Impact factor: 4.430

10.  Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression.

Authors:  Biswanath Maity; Adele Stewart; Yunxia O'Malley; Ryan W Askeland; Sonia L Sugg; Rory A Fisher
Journal:  Carcinogenesis       Date:  2013-04-18       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.